U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the COVID pandemic and has shown promise in addressing a ran ...

In recent news appearances, Department of Health and Human Services Secretary Robert F. Kennedy Jr. has suggested allowing ...

CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

Glioblastoma multiforme (GBM), commonly referred to as glioblastoma, is a malignant intracranial tumor derived from glial ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...

TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...

Mass layoffs, frozen or cut research funds, political directives — US President Donald Trump's massive attack on science is not only affecting areas he dislikes, such as climate, energy, social, or ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S.

Psychiatric disorders challenge us deeply. At the University of Arizona, researchers dissect their molecular roots, focusing ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...